<DOC>
	<DOCNO>NCT00549133</DOCNO>
	<brief_summary>To show Irbesartan improve endothelial dysfunction procoagulant state think possible mechanism , induce generalize vasculopathy associate microalbuminuria vascular event type II diabetic hypertensive patient</brief_summary>
	<brief_title>Irbesartan Effects Endothelial Dysfunction Hypertensive Type II Diabetic Patients Comparing Atenolol</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<criteria>non insulin dependent type II manifest diabetes glycosilated HbA1c level % 6.58 mild moderate hypertension stage I stage II accord ESCESH 2003 ( 140180 mmHg ) congestive heart failure azotemia insulin dependent diabetes liver insufficiency pregnancy cancer The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Microalbuminaria hypertensive patient type II diabetes mellitus</keyword>
</DOC>